Recruiting OBSERVATIONAL NCT05300997

Translational Immunodiagnostics in Stroke (TrImS) (TrImS)

Translational Immunodiagnostics in Suspected Stroke (TrImS): A Two-centre, Pragmatic, Prospective, Observational Study

Sponsor: The University of Hong Kong

Conditions Acute Ischemic Stroke Atrial Fibrillation Cardioembolic Stroke Haemorrhagic Stroke Large-Artery Atherosclerosis (Embolus/Thrombosis) Small Vessel Disease Stroke of Anterior Cerebral Artery Stroke of Basilar Artery Stroke of Middle Cerebral Artery Stroke of Other Determined Etiology Stroke of Undetermined Etiology Transient Ischemic Attacks

Interventions Biomarker blood draw and saliva collection

Updated 5 times since 2022 Last updated: May 31, 2024 Started: May 1, 2022 Primary completion: May 30, 2025 Completion: May 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Acute Ischemic Stroke and Atrial Fibrillation and is currently actively recruiting participants. The University of Hong Kong leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Sep 2022 — Jul 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
May 2022 — Sep 2022 [monthly]

Not Yet Recruiting
Apr 2022 — May 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The University of Hong Kong

Data source: The University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong, China